Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130606 · ClinicalTrials.gov registry record · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
A NA study of Hereditary Breast and Ovarian Cancer, sponsored by Georgetown University.
- Recruiting
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 2
- Study locations
NCT05130606: Recruiting NA study of Hereditary Breast and Ovarian Cancer, sponsored by Georgetown University.
NCT05130606 is a NA study of Hereditary Breast and Ovarian Cancer that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 332 participants, below the 540-participant average among 5 other Hereditary Breast and Ovarian Cancer trials with a reported enrollment target (39% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130606, a NA study of Hereditary Breast and Ovarian Cancer, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally-targeted video and referral screening tool. In this study, the investigators aim to evaluate the efficacy of a culturally targeted video previously developed by the research team vs. a Spanish-language fact sheet from an established group on enhancing genetic counseling and testing uptake and psychosocial outcomes in Latina women at risk for hereditary breast and ovarian cancer. The investigators will test the video's efficacy while also gathering data on the implementation and future sustainability of using the Risk Screening Tool (RST) and video in community clinics.
Primary Outcome
Participants will self report whether they attended a genetic counseling session in the four months following their baseline survey. The study team will also have direct access to the genetic counseling company's records.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor."
- BEHAVIORAL FORCE Fact Sheet
Study Locations (2)
District of Columbia
- Georgetown Lombardi Comprehensive Cancer Center - Washington D.C.
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05130606 shows while recruiting
NCT05130606 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 540-participant average among 5 other Hereditary Breast and Ovarian Cancer trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Hereditary Breast and Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." is the first listed.
NCT05130606 reports a single indexed study location in District of Columbia, Virginia.
Frequently Asked Questions
What is clinical trial NCT05130606 about?
NCT05130606 is a clinical study titled "CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing". This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally-targeted video and referral screening tool. In this study, the investigators aim to evaluate the e...
What is the current status of trial NCT05130606?
This trial is currently recruiting. It is a NA study. The enrollment target is 332 participants. The study started on 2021-06-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05130606 study?
This clinical trial studies the following conditions: Hereditary Breast and Ovarian Cancer.
What interventions are being tested in trial NCT05130606?
The interventions under investigation include: Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." (BEHAVIORAL), FORCE Fact Sheet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05130606?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05130606 being conducted?
This trial has 2 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Breast and Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Scalable Communication Modalities for Returning Genetic Research Results
ACTIVE NOT RECRUITING · NA
-
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
COMPLETED · NA
-
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
COMPLETED · NA
-
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
RECRUITING
-
Genetic Risk: Whether, When, and How to Tell Adolescents
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05320588 · 332 participants · Phase 1
A Study in Patients With Advanced Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI